CompletedPhase 3

High Versus Standard Dose of Proton Pump Inhibitors (PPIs) in Peptic Ulcer Bleeding

Italy450 participantsStarted 2005-01

Plain-language summary

High intravenous dosage of Proton Pump Inhibitors is not better than standard dosage in bleeding peptic ulcers successfully treated by endoscopic therapy

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Consecutive patients admitted for upper gastrointestinal bleeding secondary to peptic ulcers that have been successfully treated with endoscopic therapy Exclusion Criteria: * Variceal esophageal bleeding * Concurrent PPI use * Moribund patients

What they're measuring

Rebleeding rates and surgical needs

Trial details

NCT IDNCT00374101

SponsorCasa Sollievo della Sofferenza IRCCS

Sponsor typeOTHER

Study typeINTERVENTIONAL

View on ClinicalTrials.gov More Peptic Ulcers trials